Home

Indo Us Bio-tech Ltd EPS

Image

Indo US Bio-Tech Ltd

NSE: INDOUS

EPS

₹ 8.43

Last updated on: Dec 05, 2025

Key Highlights

  • The Earning per Share of Indo US Bio-Tech Ltd is ₹ 8.43 as of 05 Dec 25 .
  • The earning per share of Indo US Bio-Tech Ltd changed from ₹ 2.37 to ₹ 1.72 over 10 quarters. This represents a CAGR of -12.03% .

Historical Earning per Share of Indo US Bio-Tech Ltd

No data available

* All values are in

Company Fundamentals for Indo US Bio-Tech Ltd

Market Cap

257 Cr

EPS

8.4

P/E Ratio (TTM)

15.2

P/B Ratio (TTM)

3.0

Day’s High

131.65

Day’s Low

127.1

DTE

0.3

ROE

19.5

52 Week High

386.0

52 Week Low

110.3

ROCE

16.4

Market Price of Indo US Bio-Tech Ltd

1M

1Y

3Y

5Y

Monitoring Indo US Bio-Tech Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
05 Dec 2025128.35
04 Dec 2025129.1
03 Dec 2025131.95
02 Dec 2025135.95
01 Dec 2025125.65
28 Nov 2025136.05
27 Nov 2025147.75
26 Nov 2025132.4
25 Nov 2025110.35
24 Nov 2025116.6

SWOT Analysis Of Indo US Bio-Tech Ltd

Strength

2

che

Weakness

1

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Indo US Bio-Tech Ltd

Asset Value vs Market Value of Indo US Bio-Tech Ltd

Market Value

257

Asset Value

Value addition

4.4 X

47

* All values are in ₹ crores

Competitive Comparison of EPS

Company
leftMarket Capright
Indo US Bio-Tech Ltd257.37
Hindustan Unilever Ltd549569
Nestle India Ltd240393
Varun Beverages Ltd162319
Britannia Industries Ltd143584
Godrej Consumer Products Ltd116220

Historical Market Cap of Indo US Bio-Tech Ltd

No data available

* All values are in crore

Historical Revenue of Indo US Bio-Tech Ltd

No data available

* All values are in crore

Historical EBITDA of Indo US Bio-Tech Ltd

No data available

* All values are in crore

Historical Net Profit of Indo US Bio-Tech Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Indo US Bio-Tech Ltd News Hub

Indo US Bio-Tech standalone net profit rises 33.76% in the June 2024 quarter

Net profit of Indo US Bio-Tech rose 33.76% to Rs 3.17 crore in the quarter ended June 2024 as agains

Read more

09 Aug 24

Indo US Bio-Tech to announce Quarterly Result

Indo US Bio-Tech will hold a meeting of the Board of Directors of the Company on 8 August 2024. Powe

Read more

02 Aug 24

Indo US Bio-Tech to conduct AGM

Indo US Bio-Tech announced that the Annual General Meeting (AGM) of the company will be held on 30 S

Read more

18 Sept 24

Indo US Bio-Tech announces board meeting date

Indo US Bio-Tech will hold a meeting of the Board of Directors of the Company on 14 November 2024 Po

Read more

07 Nov 24

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for EPS of Indo US Bio-Tech Ltd

What is the EPS of Indo US Bio-Tech Ltd stock?

The Earnings Per Share (EPS) of Indo US Bio-Tech Ltd is 8.43. An EPS is the amount of net income attributed to each share of a common stock.

How is Indo US Bio-Tech Ltd EPS calculated?

The EPS of Indo US Bio-Tech Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Indo US Bio-Tech Ltd report its EPS?

Indo US Bio-Tech Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Indo US Bio-Tech Ltd EPS?

Factors that influence the EPS of Indo US Bio-Tech Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Indo US Bio-Tech Ltd EPS growth indicate future performance?

Yes, consistent growth in Indo US Bio-Tech Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions